Technical Analysis for PPD - PPD, Inc.

Grade Last Price % Change Price Change
A 46.27 1.03% 0.47
PPD closed up 1.03 percent on Friday, April 16, 2021, on 6.52 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical PPD trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 7.60%
New 52 Week Closing High Bullish 7.60%
Expansion Breakout Bullish Swing Setup 7.60%
Pocket Pivot Bullish Swing Setup 7.60%
Wide Range Bar Range Expansion 7.60%
New 52 Week High Strength 7.60%
Stochastic Reached Overbought Strength 7.60%
Multiple of Ten Bullish Other 7.60%
BB Squeeze Ended Range Expansion 7.60%
Above Upper BB Strength 7.60%
Older End-of-Day Signals for PPD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PPD, Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Clinical Development Pharmacy Pharmacology Drug Development Biomarker Laboratory Services Contract Research Organizations Clinical Development Services Parexel Biopharmaceutical Industry Drug Development Services Manufacturing Practice

Is PPD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 46.46
52 Week Low 21.625
Average Volume 2,605,945
200-Day Moving Average 34.46
50-Day Moving Average 37.22
20-Day Moving Average 38.92
10-Day Moving Average 40.34
Average True Range 1.49
ADX 28.83
+DI 46.19
-DI 8.27
Chandelier Exit (Long, 3 ATRs ) 41.98
Chandelier Exit (Short, 3 ATRs ) 40.13
Upper Bollinger Band 44.29
Lower Bollinger Band 33.55
Percent B (%b) 1.18
BandWidth 27.60
MACD Line 1.82
MACD Signal Line 1.00
MACD Histogram 0.8184
Fundamentals Value
Market Cap 16.18 Billion
Num Shares 350 Million
EPS 0.16
Price-to-Earnings (P/E) Ratio 282.13
Price-to-Sales 2.76
Price-to-Book 0.00
PEG Ratio 1.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.16
Resistance 3 (R3) 47.13 46.79 47.01
Resistance 2 (R2) 46.79 46.57 46.81 46.96
Resistance 1 (R1) 46.53 46.43 46.66 46.57 46.91
Pivot Point 46.20 46.20 46.26 46.22 46.20
Support 1 (S1) 45.94 45.97 46.07 45.97 45.63
Support 2 (S2) 45.60 45.83 45.62 45.58
Support 3 (S3) 45.34 45.60 45.53
Support 4 (S4) 45.38